Financial Summary (All financials)
In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
Revenues | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1,256,816.0 |
Revenue growth | | | | | | | -100.0% | 18.4% |
Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1,454,720.0 |
Gross profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -197,904.0 |
Gross margin | | | | | | | | -15.7% |
Selling, general and administrative | -107,278.7 | -100,034.0 | -94,391.0 | 0.0 | 0.0 | 0.0 | 0.0 | -727,360.0 |
EBIT | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 529,456.0 |
EBIT margin | | | | | | | | 42.1% |
Pre-tax income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 675,204.0 |
Income taxes | -276,292.7 | -103,223.0 | -173,661.0 | 0.0 | 0.0 | 0.0 | 0.0 | -79,685.0 |
Net income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Net margin | | | | | | | | 0.0% |
|
Diluted EPS | | | | | | | $0.00 | $0.00 |
Shares outstanding (diluted) | | | | | | | 97.6 | 97.6 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|